Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.
D000315:Adrenalectomy; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000601:surgery / Q000628:therapy; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D002369:Castration; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010053:Ovary; D011241:Prednisone / Q000627:therapeutic use; D011863:Radioimmunoassay; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D002272:Carcinoembryonic Antigen; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate